UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letter to the Editor: PET/CT in Locally Advanced Breast Cancer: Time for a Guideline Change?

Journal of the National Comprehensive Cancer Network, 2021-08, Vol.19 (8), p.xxx

2021

Volltextzugriff (PDF)

Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification

European radiology, 2021-08, Vol.31 (8), p.5913-5923

2021

Volltextzugriff (PDF)

Estrogen receptor‐positive/human epidermal growth factor receptor 2‐negative breast tumors

Cancer, 2013-06, Vol.119 (11), p.1960-1968

2013

Volltextzugriff (PDF)

The germline genetics of mild-to-moderate penetrance: An intriguing role of PRAME in multiple carcinogenesis

Genes & diseases, 2024-05, Vol.11 (3), p.101003-101003, Article 101003

2024

Volltextzugriff (PDF)

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases

Clinical cancer research, 2019-07, Vol.25 (14), p.4504-4515

2019

Volltextzugriff (PDF)

18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

Breast cancer research : BCR, 2017-01, Vol.19 (1), p.3-3, Article 3

2017

Volltextzugriff (PDF)

Overall survival (OS) update of the double-blind placebo (PBO)-controlled randomized phase 2 LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for locally advanced/metastatic triple-negative breast cancer (mTNBC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1008-1008

2018

Volltextzugriff (PDF)

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.377-386

2021

Volltextzugriff (PDF)

Méthotrexate intrathécal dans les méningites carcinomateuses du cancer du sein – Expérience avec le protocole utilisé à l’hôpital Saint-Louis

Bulletin du cancer, 2016-05, Vol.103 (5), p.444-454

2016

Volltextzugriff (PDF)

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

JNCI : Journal of the National Cancer Institute, 2012-12, Vol.104 (24), p.1879-1887

2012

Volltextzugriff (PDF)

Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study

Acta oncologica, 2023-12, Vol.62 (12), p.1961-1966

2023

Volltextzugriff (PDF)

Tolérance et efficacité du bévacizumab en association aux taxanes en première ligne dans le cancer du sein métastatique : étude ATHENA-France

Bulletin du cancer, 2012-06, Vol.99 (6), p.609-618

2012

Volltextzugriff (PDF)

Agonistes de la GnRH en pathologie mammaire

Annales d'urologie, 2005-10, Vol.39, p.S59-S65

ESPIE, Marc

2005

Volltextzugriff (PDF)

18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

European journal of nuclear medicine and molecular imaging, 2016-05, Vol.43 (5), p.983-993

2016

Volltextzugriff (PDF)

super(18)F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

European journal of nuclear medicine and molecular imaging, 2016-05, Vol.43 (5), p.983-993

2016

Volltextzugriff (PDF)

Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients’ With HER2-Positive Metastatic Breast Cancer

Clinical breast cancer, 2023-10, Vol.23 (7), p.e412-e419

2023

Volltextzugriff (PDF)

Expérience de l’Hôpital Saint-Louis dans le cancer du sein chez l’homme : revue des caractéristiques de 44 cas et recherche de l’expression du récepteur aux androgènes

Reproduction humaine et hormones, 2012-06, Vol.25 (1)

2012

Volltextzugriff (PDF)

Comparison of clinicopathological (CP) features and outcome of breast cancers (BC) in BRCA -mutation carriers patients, with a family history without BRCA- mutation and with sporadic disease

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13522-e13522

2018

Volltextzugriff (PDF)

Abstract PO4-13-06: Effect of neoadjuvant dose-dense dose-intense chemotherapy timing infusion on complete histological response rate among patients with triple negative breast cancer (SIMCLOCK)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-13-06-PO4-13-06

2024

Volltextzugriff (PDF)

Molecular Profiling of Inflammatory Breast Cancer

Clinical cancer research, 2004-10, Vol.10 (20), p.6789-6795

2004

Volltextzugriff (PDF)

Abstract CT140: Circulating tumor cells as a tool to guide first line therapy in metastatic breast cancer: subgroup analyses of the STIC CTC Phase III utility trial

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT140-CT140

2019

Volltextzugriff (PDF)

LOTUS (NCT02162719): A double-blind placebo (PBO)-controlled randomized phase II trial of first-line ipatasertib (IPAT) + paclitaxel (P) for metastatic triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1009-1009

2017

Volltextzugriff (PDF)

super( 18)F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

The Journal of nuclear medicine (1978), 2016-04, Vol.57 (4), p.536-536

2016

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Breast Cancer
(26)
Tumors
(13)
Chemotherapy
(11)
Cancer
(10)
Life Sciences
(10)
Oncology
(10)
Science & Technology
(10)
Life Sciences & Biomedicine
(9)
Sciences Biologiques Et Medicales
(9)
Sciences Medicales
(9)
Tumeurs
(8)
Gynecologie. Andrologie. Obstetrique
(6)
Medicine
(6)
Nuclear Medicine
(6)
Pathologie De La Glande Mammaire
(6)
Radiology
(6)
Cancer Du Sein
(5)
Medicine & Public Health
(5)
Surgery
(5)
Biological And Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Letter to the Editor: PET/CT in Locally Advanced Breast Cancer: Time for a Guideline Change?

Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification

Estrogen receptor‐positive/human epidermal growth factor receptor 2‐negative breast tumors

The germline genetics of mild-to-moderate penetrance: An intriguing role of PRAME in multiple carcinogenesis

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

Overall survival (OS) update of the double-blind placebo (PBO)-controlled randomized phase 2 LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for locally advanced/metastatic triple-negative breast cancer (mTNBC)

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Méthotrexate intrathécal dans les méningites carcinomateuses du cancer du sein – Expérience avec le protocole utilisé à l’hôpital Saint-Louis

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study

Tolérance et efficacité du bévacizumab en association aux taxanes en première ligne dans le cancer du sein métastatique : étude ATHENA-France

Agonistes de la GnRH en pathologie mammaire

18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

super(18)F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients’ With HER2-Positive Metastatic Breast Cancer

Expérience de l’Hôpital Saint-Louis dans le cancer du sein chez l’homme : revue des caractéristiques de 44 cas et recherche de l’expression du récepteur aux androgènes

Comparison of clinicopathological (CP) features and outcome of breast cancers (BC) in BRCA -mutation carriers patients, with a family history without BRCA- mutation and with sporadic disease

Abstract PO4-13-06: Effect of neoadjuvant dose-dense dose-intense chemotherapy timing infusion on complete histological response rate among patients with triple negative breast cancer (SIMCLOCK)

Molecular Profiling of Inflammatory Breast Cancer

Abstract CT140: Circulating tumor cells as a tool to guide first line therapy in metastatic breast cancer: subgroup analyses of the STIC CTC Phase III utility trial

LOTUS (NCT02162719): A double-blind placebo (PBO)-controlled randomized phase II trial of first-line ipatasertib (IPAT) + paclitaxel (P) for metastatic triple-negative breast cancer (TNBC)

super( 18)F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

Aktive Filter

Suchergebnisse filtern